Publications Office of the EU
Slovenia-Ljubljana: Pharmaceutical products - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Slovenia-Ljubljana: Pharmaceutical products

Overview
  • Awarded
    04/07/2019
  • Today
    11/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
LL Grosist družba za prodajo farmacevtskih, medicinskih in drugih proizvodov na debelo d.o.o.
Place of performance
NUTS code: SI Slovenija
Location of buyer
NUTS code: SI Slovenija
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
117,069.97
Total final contract value (excluding VAT)
234,139.94 EUR
Procedure details
Tender reference number
Not available
Description

Dobava zdravil in drugega blaga za potrebe LL Grosist d.o.o., JN 23/2019.

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
SI Slovenija
CPV code

33600000 - Pharmaceutical products

Award method
The most economic tender
Estimated value
117,069.97
Final contracted value
234,139.94 EUR
Award of contract
Official name: Javni zavod Lekarna Ljubljana
Postal address: Komenskega ulica 11
Town: Ljubljana
Postal code: 1000
Country: SVN
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.